Combined Use of Magnetization Transfer Ratio and T2-Mapping to Evaluate Extraocular Muscle Pathophysiology in Myasthenia Gravis with Ophthalmoparesis
International Journal of Medical Sciences · 2024
DOI: 10.7150/ijms.104542 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2024. Verfasst von Qin Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Myasthenia Gravis, Oculomotor Muscles, Magnetic Resonance Imaging, Ophthalmoplegia. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Myasthenia gravis (MG) is an autoimmune neuromuscular disorder that most frequently affects the extraocular muscles (EOMs), which causes symptoms such as ptosis and restricted eye movement. The EOMs in MG patients are representative of autoimmune inflammatory changes in muscle tissue. Currently, there is no reliable, and sensitive imaging technique for monitoring EOM changes to assist in the evaluation of underlying pathological changes.
Methods
This study included MG patients treated between March and November 2022 at the First Affiliated Hospital of Sun Yat-sen University. Healthy controls (matched by age and sex) were included. Participants underwent 3.0 T MRI with magnetization transfer imaging (MTI) and T2-mapping to measure the magnetization transfer ratio (MTR) and T2-mapping values in the superior, inferior, medial, and lateral rectus muscles. Comparisons were made between MG patients and healthy controls, and between MG subgroups with and without ophthalmoparesis.
Results
The MTR and T2-mapping values successfully reflected EOM fibrosis and inflammatory edema in MG patients. MG patients showed significantly higher MTR and T2-mapping values in the EOMs compared with healthy controls. MG patients with ophthalmoparesis exhibited a lower MTR but higher T2-mapping value compared with those without ophthalmoparesis. Combined MTR and T2-mapping values effectively distinguished between MG patients and healthy controls, and between different severities of EOM involvement, with a superior diagnostic accuracy compared with each parameter alone.
Conclusion
The combination of MTI and T2-mapping MRI techniques can provide key insight into the pathological changes in EOMs in MG patients. This approach enhances early diagnosis and treatment planning, and therefore may improve clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- MR Scientific Marketing, Siemens Healthineers Ltd. Guangzhou, China.
- Neuromuscular Division, Department of Neurology, Duke University Medical Center, Durham, United States.
- Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, Guangzhou, China.
- National Key Clinical Department and Key Discipline of Neurology, Guangzhou, China.
Zitieren
APA
Zhou, Q., Zhao, X., Wang, M., Li, Y., Yang, Z., Liu, W., & Chen, P. (2024). Combined Use of Magnetization Transfer Ratio and T2-Mapping to Evaluate Extraocular Muscle Pathophysiology in Myasthenia Gravis with Ophthalmoparesis. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.104542
Vancouver
Zhou Q, Zhao X, Wang M, Li Y, Yang Z, Liu W, et al. Combined Use of Magnetization Transfer Ratio and T2-Mapping to Evaluate Extraocular Muscle Pathophysiology in Myasthenia Gravis with Ophthalmoparesis. International Journal of Medical Sciences. 2024. doi:10.7150/ijms.104542
BibTeX
@article{Zhou2024,
author = {Zhou, Qin and Zhao, Xiaoxiao and Wang, Mengzhu and Li, Yingkai and Yang, Zhiyun and Liu, Weibin and Chen, Pei},
title = {Combined Use of Magnetization Transfer Ratio and T2-Mapping to Evaluate Extraocular Muscle Pathophysiology in Myasthenia Gravis with Ophthalmoparesis},
journal = {International Journal of Medical Sciences},
year = {2024},
doi = {10.7150/ijms.104542}
}
EUVIMED